Name: ZOMEDICA CORP (ZOM) Stock
Brand: ZOMEDICA CORP
Rating: 5.5 (3 reviews)

ZOM Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: ACCESS Newswire

Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets

13 days ago - By: ACCESS Newswire

Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union

18 days ago - By: ACCESS Newswire

Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar

a month ago - By: ACCESS Newswire

Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay

a month ago - By: ACCESS Newswire

Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents

a month ago - By: ACCESS Newswire

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging

2 months ago - By: ACCESS Newswire

Zomedica and UXR Announce Expanded Distribution Agreement in Canada

3 months ago - By: ACCESS Newswire

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets

4 months ago - By: ACCESS Newswire

Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala

2 months ago - By: ACCESS Newswire

Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio

2 months ago - By: ACCESS Newswire

Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices

3 months ago - By: ACCESS Newswire

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine

3 months ago - By: ACCESS Newswire

Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth

4 months ago - By: ACCESS Newswire

Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope

4 months ago - By: ACCESS Newswire

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics

6 months ago - By: ACCESS Newswire

Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy

8 months ago - By: ACCESS Newswire

Zomedica Corp. Announces Transition to OTCQB Venture Market

9 months ago - By: ACCESS Newswire

Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters

9 months ago - By: ACCESS Newswire

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis

5 months ago - By: ACCESS Newswire

Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution

5 months ago - By: ACCESS Newswire

Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations

7 months ago - By: Yahoo Finance - Mentions: COMP DHI CMG TSLA

Zomedica Corp. (ZOMDF): Among Stocks Insiders Were Buying In Q1 2025

8 months ago - By: Benzinga - Mentions: VERI USEG EVCM PHAR ...

Earnings Scheduled For March 13, 2025

8 months ago - By: ACCESS Newswire

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

10 months ago - By: Benzinga

ZOMEDICA CORP (ZOM) Stock News

ZOM Latest News, Press Relases and Analysis

Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets

Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union

Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar

Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay

Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging

Zomedica and UXR Announce Expanded Distribution Agreement in Canada

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets

Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala

Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio

Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine

Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth

Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics

Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy

Zomedica Corp. Announces Transition to OTCQB Venture Market

Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis

Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution

Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations

Zomedica Corp. (ZOMDF): Among Stocks Insiders Were Buying In Q1 2025

Earnings Scheduled For March 13, 2025

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health